Celldex Therapeutics, Inc. · NASDAQ:CLDX

Kynam Capital Management, LP reported a 9.79% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Kynam Capital Management, LP reported a 9.79% stake in Celldex Therapeutics, Inc., 6,500,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
9.79%
Shares
6,500,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP9.79%6,500,000
Kynam Capital Management GP, LLC9.79%6,500,000
Yue Tang9.79%6,500,000

Source

View original at SEC

Related